TRDA Insider Trading Activity and SEC Form 4 Filings
TRDA insider trading summary
Over the past 12 months, insiders at Entrada Therapeutics, Inc. (TRDA) reported 119 sales worth $36.5M by 23 insiders and 65 open-market purchases worth $6.5M by 5 insiders on SEC Form 4. Net insider selling was $30.0M.
Latest TRDA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Todd Foley | 10% Owner | Sell | $309K (44,259 @ $6.99) |
| Aug 31, 2026 | Mpm Asset Management Investors Bv2018 LLC | 10% Owner | Sell | $309K (44,259 @ $6.99) |
| Aug 31, 2026 | Luke Evnin | 10% Owner | Sell | $309K (44,259 @ $6.99) |
| Aug 31, 2026 | MPM BioVentures 2014 LLC | 10% Owner | Sell | $309K (44,259 @ $6.99) |
| Aug 31, 2026 | MPM Asset Management Investors BV2014 LLC | 10% Owner | Sell | $309K (44,259 @ $6.99) |
| Aug 31, 2026 | MPM BioVentures 2014 GP LLC | 10% Owner | Sell | $309K (44,259 @ $6.99) |
| Aug 31, 2026 | Ansbert Gadicke | 10% Owner | Sell | $309K (44,259 @ $6.99) |
| Aug 31, 2026 | MPM BioVentures 2014, L.P. | Insider | Sell | $309K (44,259 @ $6.99) |
| Aug 31, 2026 | MPM BioVentures 2014 (B), L.P. | 10% Owner | Sell | $309K (44,259 @ $6.99) |
| Aug 31, 2026 | Mpm Bioventures 2018 (b), L.P. | 10% Owner | Sell | $309K (44,259 @ $6.99) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.